These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 233033)

  • 1. On the molecular structure of some prostaglandin receptors.
    Smythies JR
    Prostaglandins Med; 1979 May; 2(5):393-400. PubMed ID: 233033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible molecular structure of binding sites for tumor-promoting phorbol esters, 2'-deacyl phospholipids and PGE1 on the molecule of phospholipase A2.
    Smythies JR
    J Theor Biol; 1979 Dec; 81(3):401-5. PubMed ID: 537380
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of phospholipase A2 and prostaglandin E in growth and differentiation of myeloid leukemic cells.
    Simantov R; Sachs L
    Biochim Biophys Acta; 1982 Apr; 720(2):111-9. PubMed ID: 6979351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the molecular structure of receptors for co-carcinogens and some anti-cancer drugs.
    Smythies JR; Benington F; Morin RD
    Psychoneuroendocrinology; 1975; 1(2):123-30. PubMed ID: 1234651
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium dependency of prostaglandin E2 production in rat glomerular mesangial cells. Evidence that protein kinase C modulates the Ca2+-dependent activation of phospholipase A2.
    Bonventre JV; Swidler M
    J Clin Invest; 1988 Jul; 82(1):168-76. PubMed ID: 3164726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some properties of prostaglandin E2 receptors in rabbit alveolar bone cell membranes.
    Yoshizawa Y; Abiko Y; Takiguchi H
    Int J Biochem; 1983; 15(8):991-5. PubMed ID: 6137425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and cancer: further stereochemical studies on the molecule of phospholipase A2.
    Symthies JR
    Psychoneuroendocrinology; 1980 Dec; 5(4):353-8. PubMed ID: 7208752
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potent anti-tumor-promoting agent isoliquiritigenin.
    Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
    Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotheses on the molecular mechanism of action of tumor promoters.
    Smythies JR
    Med Hypotheses; 1981 Jun; 7(6):711-7. PubMed ID: 7278734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interfacial catalysis: the mechanism of phospholipase A2.
    Scott DL; White SP; Otwinowski Z; Yuan W; Gelb MH; Sigler PB
    Science; 1990 Dec; 250(4987):1541-6. PubMed ID: 2274785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into metal ion binding in phospholipases A2: ultra high-resolution crystal structures of an acidic phospholipase A2 in the Ca2+ free and bound states.
    Murakami MT; Gabdoulkhakov A; Genov N; Cintra AC; Betzel C; Arni RK
    Biochimie; 2006 May; 88(5):543-9. PubMed ID: 16376474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids antagonize the induction of ornithine decarboxylase activity by phorbol esters and phospholipase C in rat tracheal epithelial cells.
    Jetten AM; Shirley JE
    J Cell Physiol; 1985 Jun; 123(3):386-94. PubMed ID: 3921556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2.
    Dijkstra BW; Renetseder R; Kalk KH; Hol WG; Drenth J
    J Mol Biol; 1983 Jul; 168(1):163-79. PubMed ID: 6876174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of prostaglandin E2 synthesis by exogenous phospholipase A2 and C in rabbit kidney medulla slices.
    Fujimoto Y; Akamatsu N; Hattori A; Fujita T
    Biochem J; 1984 Feb; 218(1):69-74. PubMed ID: 6585201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-binding capability of pancreatic phospholipase A2 is separable from its enzymatic activity.
    Ishizaki J; Kishino J; Teraoka H; Ohara O; Arita H
    FEBS Lett; 1993 Jun; 324(3):349-52. PubMed ID: 8405380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.